Autor segons l'article: Lopez, JE; Perez, JE; Mallafre, RS; Villaro, FF; Tarrago, AC; Perez, BE; Serafini, JF; Martin, RJ
Departament: Ciències Mèdiques Bàsiques
Autor/s de la URV: Elvira Lopez, Jordi / Escuder Pérez, Jorge / Feliu Villaró, Francesc / Jorba Martin, Rosa Maria / Sales Mallafré, Ricard
Paraules clau: Sinus disease Sacrococcygeal fistula pilonidal sinus Pilonidal disease of natal cleft Pilonidal disease Phenolization Phenol sacrococcygeal fistula pilonidal sinus risk pilonidal disease of natal cleft pilonidal disease phenolization phenol classification
Resum: To test the efficacy and safety of phenolization in uncomplicated Sacrococcygeal pilonidal disease (SPD) the phenolization in uncomplicated SPD is feasible and secure in selected patients in observational studies. The greatest benefits are obtained to reduce the length of sick leave (LSL) and complications. Single-center randomised controlled clinical trial. Patients were recruited at University Hospital of Tarragona Joan XXIII of Spain. Patients were randomised into two treatment groups. All patients with uncomplicated sacrococcygeal disease, localised in the midline and with only 1 fistulous orifice. The patients were randomly assigned to the phenolization group (PhG) or conventional-surgery group (CsG). Both groups were managed without admission. The main endpoint was the recurrence of sacrococcygeal disease. Secondary endpoints included time of sick leave, complications, and readmission. 124 patients were included in the study. No disease recurrence was observed in either group. Clinical follow-up was carried out with a mean of 493.8 days (SD 6.59). The LSL was shorter in the PhG (mean 19.63 days, SD 28.15) than in the CSG (43.95 days, SD 38.60). The LSL reduction was −24.31 days (P.002). The phenolization in selected SPD is a safe and feasible procedure in selected patients. This approach could become the standard of care for patients with selected Sacrococcygeal pilonidal.
Àrees temàtiques: Surgery Odontología Medicina iii Medicina ii Medicina i Interdisciplinar Farmacia Educação física Dermatology Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências agrárias i Biotecnología
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: ricard.sales@urv.cat jordi.elvira@urv.cat francesc.feliu@urv.cat jorge.escuder@urv.cat ricard.sales@urv.cat jordi.elvira@urv.cat rosamaria.jorba@urv.cat
Identificador de l'autor: 0000-0003-1700-9813 0000-0003-1700-9813 0000-0003-3307-4340
Data d'alta del registre: 2024-08-03
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://onlinelibrary.wiley.com/doi/10.1111/iwj.14096
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: International Wound Journal. 20 (6): 2181-2189
Referència de l'ítem segons les normes APA: Lopez, JE; Perez, JE; Mallafre, RS; Villaro, FF; Tarrago, AC; Perez, BE; Serafini, JF; Martin, RJ (2023). Randomised clinical trial to test the phenolization in sacrococcygeal pilonidal disease. International Wound Journal, 20(6), 2181-2189. DOI: 10.1111/iwj.14096
DOI de l'article: 10.1111/iwj.14096
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2023
Tipus de publicació: Journal Publications